Becker Hewes

Becker Hewes is Chief Medical Officer at Damora Therapeutics, where he oversees clinical development of therapies targeting mutant calreticulin-driven blood disorders. Previously, he was Chief Medical Officer at Blueprint Medicines, where he led development programs including AYVAKIT, approved for systemic mastocytosis.

Career

Cosigned byLoading...

CosignedSign in to view

Based in: Cambridge

Damora Therapeutics

Until Present

Chief Medical Officer

Georgetown University School of Medicine

M.D.

Vanderbilt University

B.S.

Profile name

Company name

Company name

Profile name

Company name

Company name

Profile name

Company name

Company name

Profile name

Company name

Company name

Profile name

Company name

Company name

Becker Hewes

Damora Therapeutics

Georgetown University School of Medicine

Vanderbilt University

Curated Lists

List Inclusions